Clinical Trials
AI-first clinical research solutions that modernise trial design, execution, and evidence generation while meeting regulatory and operational demands.
Clinical Trials
AI-first clinical research solutions that modernise trial design, execution, and evidence generation while meeting regulatory and operational demands.
Case Study
Transforming spinal injury rehabilitation
Neuromuscular feedback in Paraplegia Care – the latest clinical trial study powered by Huma
Case Study
Real-world evidence. Research without friction.
4,500 patients recruited a full year ahead of schedule — setting the stage for breakthrough insights to improve kidney and diabetes care worldwide
Case Study
Forging the next infrastructure for pediatric life support
Huma’s regulated, disease-agnostic platform powers a real-world data investigation modernising neonatal and pediatric critical care.
Case Study
Huma infrastructure redefining real-world insomnia research
Huma’s regulated, disease-agnostic platform powers Idorsia’s non-interventional ProDiGy study, generating real-world evidence on insomnia treatment across Germany and Austria.
Case Study
A landmark for risk-model lung cancer screening
Powered by Huma’s platform, HANSE validates PLCOm2012 for nationwide adoption, forming Germany’s 2026 lung cancer screening blueprint.
Case Study
Turning oncology data into regulated evidence
After a decade of continuous real-world observation, Huma’s regulated research infrastructure enabled the VARGADO study to translate longitudinal oncology data into durable, peer-reviewed evidence at clinical scale.
Case Study
Transforming spinal injury rehabilitation
Neuromuscular feedback in Paraplegia Care – the latest clinical trial study powered by Huma
Case Study
Real-world evidence. Research without friction.
4,500 patients recruited a full year ahead of schedule — setting the stage for breakthrough insights to improve kidney and diabetes care worldwide
Case Study
Forging the next infrastructure for pediatric life support
Huma’s regulated, disease-agnostic platform powers a real-world data investigation modernising neonatal and pediatric critical care.
Case Study
Huma infrastructure redefining real-world insomnia research
Huma’s regulated, disease-agnostic platform powers Idorsia’s non-interventional ProDiGy study, generating real-world evidence on insomnia treatment across Germany and Austria.
Case Study
A landmark for risk-model lung cancer screening
Powered by Huma’s platform, HANSE validates PLCOm2012 for nationwide adoption, forming Germany’s 2026 lung cancer screening blueprint.
Case Study
Turning oncology data into regulated evidence
After a decade of continuous real-world observation, Huma’s regulated research infrastructure enabled the VARGADO study to translate longitudinal oncology data into durable, peer-reviewed evidence at clinical scale.
Case Study
Transforming spinal injury rehabilitation
Neuromuscular feedback in Paraplegia Care – the latest clinical trial study powered by Huma
Case Study
Real-world evidence. Research without friction.
4,500 patients recruited a full year ahead of schedule — setting the stage for breakthrough insights to improve kidney and diabetes care worldwide
Case Study
Forging the next infrastructure for pediatric life support
Huma’s regulated, disease-agnostic platform powers a real-world data investigation modernising neonatal and pediatric critical care.
Case Study
Huma infrastructure redefining real-world insomnia research
Huma’s regulated, disease-agnostic platform powers Idorsia’s non-interventional ProDiGy study, generating real-world evidence on insomnia treatment across Germany and Austria.
Case Study
A landmark for risk-model lung cancer screening
Powered by Huma’s platform, HANSE validates PLCOm2012 for nationwide adoption, forming Germany’s 2026 lung cancer screening blueprint.
Case Study
Turning oncology data into regulated evidence
After a decade of continuous real-world observation, Huma’s regulated research infrastructure enabled the VARGADO study to translate longitudinal oncology data into durable, peer-reviewed evidence at clinical scale.
Case Study
Transforming spinal injury rehabilitation
Neuromuscular feedback in Paraplegia Care – the latest clinical trial study powered by Huma
Case Study
Real-world evidence. Research without friction.
4,500 patients recruited a full year ahead of schedule — setting the stage for breakthrough insights to improve kidney and diabetes care worldwide
Case Study
Forging the next infrastructure for pediatric life support
Huma’s regulated, disease-agnostic platform powers a real-world data investigation modernising neonatal and pediatric critical care.
Case Study
Huma infrastructure redefining real-world insomnia research
Huma’s regulated, disease-agnostic platform powers Idorsia’s non-interventional ProDiGy study, generating real-world evidence on insomnia treatment across Germany and Austria.
Case Study
A landmark for risk-model lung cancer screening
Powered by Huma’s platform, HANSE validates PLCOm2012 for nationwide adoption, forming Germany’s 2026 lung cancer screening blueprint.
Case Study
Turning oncology data into regulated evidence
After a decade of continuous real-world observation, Huma’s regulated research infrastructure enabled the VARGADO study to translate longitudinal oncology data into durable, peer-reviewed evidence at clinical scale.